Home » Tocilizumab, a domestic drug for the treatment of severe COVID-19, was approved and can be put into production immediately|New Crown Pneumonia_Sina Finance_Sina.com

Tocilizumab, a domestic drug for the treatment of severe COVID-19, was approved and can be put into production immediately|New Crown Pneumonia_Sina Finance_Sina.com

by admin
Tocilizumab, a domestic drug for the treatment of severe COVID-19, was approved and can be put into production immediately|New Crown Pneumonia_Sina Finance_Sina.com

Reposted from: Finance Association

[The domestic new crown severe treatment drug tocilizumab was approved and can be put into production immediately]”Kechuangban Daily” news on the 30th, the reporter fromBio-TheraIt was learned that the company’s tocilizumab injection, Serelix, can be put into production immediately after it is approved for marketing. The drug has already had a pre-production process before it goes on the market, and the production capacity can guarantee market demand. Bio-Thera announced on the evening of the 29th that it has recently received the “Drug Registration Certificate” for Tocilizumab Injection Shiruili approved and issued by the State Food and Drug Administration. At present, tocilizumab injection is included in the “Diagnosis and Treatment Program for Novel Coronavirus Infection (Trial Version 10)” and “Diagnosis and Treatment Program for Severe Cases of New Coronavirus Infection (Trial Version 4)”. -6 level significantly increased can try. (Reporter Zhu Jieyan)

Massive information, accurate interpretation, all in the Sina Finance APP

See also  NVIDIA warns of mining card collapse: a large number of second-hand graphics cards will hit the game market - nVIDIA - cnBeta.COM

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy